Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for treating Attention-Deficit/Hyperactivity Disorder in children and people. This functions as a prodrug, meaning it’s https://apo-lisdexamfetamine-pri434261.ourcodeblog.com/43514797/vyvanse-in-canada-a-comprehensive-guide